Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Applikon Biotechnology
Applikon Biotechnology
X
LinkedIn
Trending Articles
Knowledge and adaptability drive successful pharmaceutical outsourcing partnerships
Third-party contract manufacturers and packers play an increasingly prominent role in the pharmaceutical sector, helping companies to both navigate the complexities of the...
dsm-firmenich showcases excipient and sustainability solutions at CPHI Milan
The company will present its range of solutions designed to boost patient compliance, while also exhibiting its pharma-grade CBD ingredient
Roche's cancer immunotherapy Tecentriq Hybreza bags FDA approval
The drug first and only subcutaneous PD-(L)1 inhibitor available for patients with certain types of lung, skin, liver and soft tissue cancers
Moderna's mRNA manufacturing facility bags Canadian Drug Establishment License
The Canadian facility can now domestically manufacture a range of mRNA vaccines to treat respiratory viruses
Genesis Pharma to distribute Santhera's Agamree for DMD
The therapeutic recently received EC approval to treat patients over 4 years old with Duchenne muscular dystrophy
Upcoming event
Boston Biotech Week
23-26 September, 2024 | Convention and exhibition | Boston, US
See all
Related Content
You need to be a subscriber to read this article.
Click here
to find out more.
Pharmaceutical
Diversity aids a biotech boom
The biotech sector is boosted by invention and shows no sign of slowing. Biopharmaceutical pipelines are broadening and production techniques improving. Susan Birks reports
Manufacturing
Microbioreactor rapidly handles microbial strains, clone libraries and cells
Micro-Matrix offers 24 independent bioreactors in microtitre plate footprint
Manufacturing
Applikon Biotechnology officially opens a new production facility in China
Event will be combined with a scientific seminar on bioreactor technology innovations
Manufacturing
King Willem-Alexander of the Netherlands to open new headquarters of Applikon Biotechnology
New facility includes offices, R&D laboratories and a state-of-the-art warehouse
Manufacturing
Applikon Biotechnology starts construction of new facility in Delft
The building will accommodate 100 people and be completed next summer
Subscribe now